A total of 617 genes were identified that are most likely to influence the TCA cycle, and showed significant enrichment of tumor-associated pathways such as Myc targets v1, coagulation, estrogen response, EMT, and myogenesis (Figure 1E). The gene discussed is MYC; the disease is neoplasm.